A unique 3D printable material which will revolutionise implantable medical devices.

4D Medicines have developed a totally new biodegradable polymer, 4 Degra that can be 3D Printed to provide devices for a multitude of implantable devices including orthopaedic repair, slow drug release, cosmetic dermal fillers and many other applications. They expect their first regulatory approval this year for an orthopaedic screw with improved performance over existing devices 4D Medicines has already turned down an earn-out acquisition offer of £38M and has a supportive investor group including DSW Ventures, Oshen Holdings, Boundary Capital and Nikulu Investments.

Existing resorbable medical polymers such as PLA, PLGA and PCL are limited byAdvance Resorbable Biomaterial Technology their properties problematic degradation/biocompatibility and they cannot be 3D printed into complex or very small structures 4Degra is a unique, multiple patent-protected platform technology and the ONLY route to 3D Printing high resolution or small biodegradable medical devices.

http://4dmedicine.co.uk

Product4D Medicine
SectorMedical
Aim of fundingAdvance
HMRC Advanced Assurance receivedHMRC
Envisaged investor exit5-7 years
Targeted return5x